Serina Therapeutics (SER) Interest Coverage Ratio (2018 - 2026)
Serina Therapeutics (SER) posted Interest Coverage Ratio of 36.09 for Q4 2025, up 86.45% sequentially from 266.33 in Q3 2025, and down 134.12% YoY from 105.76 in Q4 2024.
Serina Therapeutics (SER) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported Interest Coverage Ratio for 8 years, with the latest figure at 36.09 in Q4 2025.
- Quarterly Interest Coverage Ratio fell 134.12% year-over-year to 36.09 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 54.84 (down 20.32% YoY) and the FY2025 annual result came in at 0.54, up 98.32% from the prior year.
- Interest Coverage Ratio grew to 36.09 in Q4 2025 per SER's latest filing, from 266.33 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1.24 in Q4 2023 and troughed at 551.25 in Q2 2021.
- A 5-year average of 72.95 and a median of 12.36 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2022: Interest Coverage Ratio tumbled 5067.97% in 2021, then jumped 99.67% in 2022.
- Over 5 years, Interest Coverage Ratio stood at 5.87 in 2021, then soared by 71.41% to 1.68 in 2022, then climbed by 26.02% to 1.24 in 2023, then tumbled by 1140.79% to 15.41 in 2024, then sank by 134.12% to 36.09 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 36.09, 266.33, and 14.23 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 1.42 |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | -33.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.49 |
| Dec 31, 2025 | -36.09 |
| Sep 30, 2025 | -266.33 |
| Jun 30, 2025 | -14.23 |
| Mar 31, 2025 | -13.53 |
| Dec 31, 2024 | -15.41 |
| Sep 30, 2024 | -45.40 |
| Jun 30, 2024 | -6.28 |
| Mar 31, 2024 | -3.40 |
| Dec 31, 2023 | -1.24 |
| Sep 30, 2023 | -14.63 |
| Jun 30, 2023 | -8.75 |
| Mar 31, 2023 | -11.19 |
| Sep 30, 2022 | -1.68 |
| Jun 30, 2022 | -1.84 |
| Mar 31, 2022 | -3.59 |
| Sep 30, 2021 | -5.87 |
| Jun 30, 2021 | -551.25 |
| Mar 31, 2021 | -312.43 |
| Sep 30, 2020 | -21.79 |